Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIp Group Share News (IPO)

Share Price Information for Ip Group (IPO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 49.05
Bid: 48.80
Ask: 48.95
Change: -0.50 (-1.01%)
Spread: 0.15 (0.307%)
Open: 49.30
High: 49.40
Low: 48.35
Prev. Close: 49.55
IPO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

Tue, 16th Jan 2024 09:14

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

----------

FTSE 100

----------

JPMorgan cuts Rightmove to 'underweight' (neutral) - price target 493 (585) pence

----------

Goldman Sachs raises Rightmove price target to 667 (659) pence - 'neutral'

----------

JPMorgan cuts HSBC price target to 660 (690) pence - 'neutral'

----------

JPMorgan cuts Standard Chartered price target to 820 (990) pence - 'overweight'

----------

Jefferies cuts Standard Chartered price target to 1,050 (1,100) pence - 'buy'

----------

JPMorgan cuts NatWest price target to 260 (280) pence - 'overweight'

----------

JPMorgan cuts Barclays price target to 180 (190) pence - 'overweight'

----------

Jefferies raises Berkeley price target to 4,706 (4,572) pence - 'hold'

----------

Jefferies raises Barratt Developments price target to 583 (470) pence - 'hold'

----------

Peel Hunt cuts Taylor Wimpey to 'hold' (add) - price target 145 (125) pence

----------

Jefferies raises Taylor Wimpey price target to 172 (143) pence - 'buy'

----------

JPMorgan raises Taylor Wimpey price target to 101 (96) pence - 'neutral'

----------

Citigroup raises Beazley price target to 723 (680) pence - 'buy'

----------

Citigroup cuts Prudential price target to 1130 (1350) pence - 'buy'

----------

UBS cuts Rentokil Initial price target to 375 (460) pence - 'sell'

----------

Goldman Sachs raises Auto Trader group price target to 886 (863) pence - 'buy'

----------

Barclays cuts Croda International target to 5,000 (6,300) pence - 'equal weight'

----------

Goldman Sachs raises WPP price target to 870 (849) pence - 'neutral'

----------

Goldman Sachs raises Informa price target to 1,027 (1,019) pence - 'buy'

----------

Goldman Sachs raises Relx price target to 3,795 (3,405) pence - 'buy'

----------

Goldman Sachs raises Pearson price target to 1,319 (1,225) pence - 'buy'

----------

Berenberg cuts Rolls-Royce to 'sell' (hold) - price target 240 (100) pence

----------

Bernstein raises Convatec price target to 305 (285) pence - 'outperform'

----------

Morgan Stanley raises AstraZeneca price target to 13,400 (12,900) pence - 'overweight'

----------

UBS cuts AstraZeneca to 'sell' (buy) - price target 10,700 (13,000) pence

----------

Morgan Stanley raises GSK price target to 1730 (1535) pence - 'equal-weight'

----------

UBS raises GSK to 'buy' (sell) - price target 1,860 (1,310) pence

----------

Citigroup raises St James's Place price target to 667 (660) pence - 'neutral'

----------

Citigroup raises Phoenix price target to 509 (501) pence - 'neutral'

----------

Citigroup raises M&G price target to 223 (208) pence - 'neutral'

----------

Citigroup raises Legal & General price target to 254 (232) pence - 'neutral'

----------

Citigroup raises Aviva price target to 450 (422) pence - 'neutral'

----------

Deutsche Bank cuts Diageo price target to 2,450 (2,470) pence - 'sell'

----------

Goldman Sachs raises Experian price target to 4,250 (4,000) pence - 'buy'

----------

FTSE 250

----------

RBC starts Premier Foods with 'outperform' - price target 180 pence

----------

Citigroup raises Hiscox price target to 1,084 (1,032) pence - 'neutral'

----------

RBC cuts PageGroup price target to 550 (560) pence - 'outperform'

----------

Barclays raises Spire Healthcare price target to 315 (305) pence - 'overweight'

----------

Berenberg raises Direct Line to 'buy' (hold) - price target 195 (170) pence

----------

Jefferies raises Redrow price target to 774 (635) pence - 'buy'

----------

Jefferies raises Vistry price target to 1,023 (831) pence - 'hold'

----------

Citigroup cuts Drax to 'sell' (buy) - price target 437 (474) pence

----------

Barclays cuts Johnson Matthey target to 2,030 (2,100) pence - 'equal weight'

----------

Goldman Sachs cuts ITV to 'sell' (neutral) - price target 60 (67) pence

----------

Jefferies raises Persimmon to 'buy' (hold) - price target 1,706 (1,181) pence

----------

Jefferies cuts Crest Nicholson to 'hold' (buy) - price target 234 (331) pence

----------

Jefferies raises Bellway price target to 3,301 (2,827) pence - 'buy'

----------

Jefferies cuts Moneysupermarket.com to 'hold' (buy) - price target 265 (305) pence

----------

JPMorgan raises Ashmore price target to 185 (183) pence - 'underweight'

----------

SMALL CAP

----------

Numis cuts Wise to 'hold' (buy) - price target 950 pence

----------

Morgan Stanley raises Wise price target to 1,070 (1,050) pence - 'overweight'

----------

Goldman Sachs raises Wise price target to 1,250 (1,200) pence - 'buy'

----------

Goldman Sachs raises Wise price target to 1,250 (1,200) pence - 'buy'

----------

UBS cuts Card Factory price target to 107 (109) pence - 'neutral'

----------

investec cuts Reach to 'hold' (buy) - price target 70 (100) pence

----------

Peel Hunt raises Oxford Nanopore to 'reduce' (sell) - price target 155 pence

----------

Barclays raises Synthomer price target to 416 (187) pence - 'equal weight'

----------

JPMorgan cuts Bank of Ireland to 'underweight' (neutral) - price target 8 (10.80) EUR

----------

JPMorgan cuts AIB price target to 4.80 (5.80) EUR - 'overweight'

----------

Copyright 2024 Alliance News Ltd. All Rights Reserved.

More News
5 Aug 2021 08:49

IP Group launches share buyback as interim profits surge

(Sharecast News) - Intellectual property-based business developer IP Group said on Thursday that it will launch a £20.0m share buyback after witnessing a rise in interim profits.

Read more
29 Jul 2021 16:00

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
27 Jul 2021 12:07

IP Group's Artios raises USD153 million for cancer therapy pipeline

IP Group's Artios raises USD153 million for cancer therapy pipeline

Read more
27 Jul 2021 09:18

IP Group portfolio company completes Series C financing

(Sharecast News) - Intellectual property-based business investor IP Group said on Tuesday that portfolio company Artios Pharma had completed a $153.0m Series C financing to fund the further development of its clinical-stage pipeline.

Read more
28 Jun 2021 13:41

IN BRIEF: IP Group Non-Exec Director Hynes buys 21,000 shares

IN BRIEF: IP Group Non-Exec Director Hynes buys 21,000 shares

Read more
17 Jun 2021 09:48

IP Group investee Apollo Therapeutics completes USD145 million raise

IP Group investee Apollo Therapeutics completes USD145 million raise

Read more
17 Jun 2021 07:40

IP Group portfolio business raises $145m in financing round

(Sharecast News) - Intellectual property business IP Group said on Thursday that portfolio company Apollo Therapeutics had completed a $145.0m financing round.

Read more
9 Jun 2021 16:08

UK dividends calendar - next 7 days

UK dividends calendar - next 7 days

Read more
9 Jun 2021 14:27

IN BRIEF: IP Group invests GBP250,000 in GBP1.1 million Itaconix raise

IN BRIEF: IP Group invests GBP250,000 in GBP1.1 million Itaconix raise

Read more
9 Jun 2021 09:21

IN BRIEF: IP Group expects GBP80 million in first half realisations

IN BRIEF: IP Group expects GBP80 million in first half realisations

Read more
9 Jun 2021 08:01

IP Group preparing for first divi as portfolio progress continues

(Sharecast News) - Intellectual property business developer IP Group said on Wednesday that for the year to date, its positive progress made by many of its portfolio companies in 2020 had continued.

Read more
7 Jun 2021 09:24

IP Group sells part of Iksuda Therapeutics stake in financing round

IP Group sells part of Iksuda Therapeutics stake in financing round

Read more
7 Jun 2021 07:25

IP Group portfolio co Iksuda raises £42m to develop cancer drug

(Sharecast News) - Intellectual property business developer IP Group said its portfolio company Iksuda Therapeutics had completed a $42m (£29m) financing round to fund human clinical trials of its lead cancer drug.

Read more
2 Jun 2021 15:55

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days

Read more
28 May 2021 15:12

IP Group launches joint venture aiming to provide capital in China

IP Group launches joint venture aiming to provide capital in China

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.